BIPAR SCIENCES

bipar-sciences-logo

BiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar's key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors. BiPar has raised around $60 million in VC funding, from firms like [Domain Associates](/financial-organization/domain-associates), [Canaan Partners](/financial-organization/canaan-partners-3), [Vulcan Capital](/financial-organization/vulcan-capital), [PolyTechnos Ven... ture Partners](/financial-organization/polytechnos-venture-partners), [Asset Management Company](/financial-organization/asset-management), and [Quantum Technology Partners](/financial-organization/quantum-technology-partners). It also has raised venture debt from [Lighthouse Capital Partners](/financial-organization/lighthouse-capital-partners). On April 15th, 2009, French drug maker [Sanofi-Aventis S.A.](/organization/sanofi-aventis-2) announced it was acquiring BiPar Sciences for up to $500 million.

#People #Financial #Website #More

BIPAR SCIENCES

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2002-01-01

Address:
Brisbane, California, United States

Country:
United States

Website Url:
http://www.biparsciences.com

Total Employee:
11+

Status:
Active

Contact:
650-635-6050

Total Funding:
74.97 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Nginx Baidu Analytics DNS.COM


Current Employees Featured

not_available_image

Deborah A. Thomas, Ph.D.
Deborah A. Thomas, Ph.D. Vice President, Regulatory Affairs @ BiPar Sciences
Vice President, Regulatory Affairs

not_available_image

Charles Bradley, Ph.D.
Charles Bradley, Ph.D. Vice President, Clinical Development @ BiPar Sciences
Vice President, Clinical Development

not_available_image

John Schembri
John Schembri Chief Financial Officer @ BiPar Sciences
Chief Financial Officer

not_available_image

Barry Sherman, M.D.
Barry Sherman, M.D. Executive Vice President, Development @ BiPar Sciences
Executive Vice President, Development

Founder


tom-white_image

Tom White

Investors List

vulcan-capital_image

Vulcan Capital

Vulcan Capital investment in Series C - BiPar Sciences

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series C - BiPar Sciences

polytechnos-venture-partners_image

PolyTechnos Venture Partners

PolyTechnos Venture Partners investment in Series C - BiPar Sciences

asset-managementcompany_image

Asset Management Company

Asset Management Company investment in Series C - BiPar Sciences

asset-management-ventures_image

Asset Management Ventures (AMV)

Asset Management Ventures (AMV) investment in Series C - BiPar Sciences

domain-associates_image

Domain Associates

Domain Associates investment in Series C - BiPar Sciences

quantum-technology-partners_image

Quantum Technology Partners

Quantum Technology Partners investment in Series C - BiPar Sciences

sand-hill-angels_image

Sand Hill Angels

Sand Hill Angels investment in Series B - BiPar Sciences

asset-managementcompany_image

Asset Management Company

Asset Management Company investment in Series B - BiPar Sciences

sand-hill-angels_image

Sand Hill Angels

Sand Hill Angels investment in Series A - BiPar Sciences

Official Site Inspections

http://www.biparsciences.com

  • Host name: 83.229.75.207
  • IP address: 83.229.75.207
  • Location: Nigeria
  • Latitude: 10
  • Longitude: 8
  • Timezone: Africa/Lagos

Loading ...

More informations about "BiPar Sciences" on Search Engine